SEC Company Response from Intersect ENT, Inc. (CIK 0001271214) — Jun 15, 2020
Intersect ENT, Inc. (CIK 0001271214)
Date: June 15, 2020 · CIK: 0001271214 · Accession: 0001193125-20-168819
AI Filing Summary & Sentiment
File numbers found in text: 333-238963
Letter
Acceleration Request
INTERSECT ENT, INC.
1555 Adams Drive
Menlo Park, CA
June 15, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada D. Sarmento
RE: Intersect ENT, Inc.
Registration Statement on Form S-3
File No. 333-238963
Acceleration Request
Requested Date: June 17, 2020
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-238963) (the “Registration Statement”) to become effective at 4:00 p.m. Eastern Time on Wednesday, June 17, 2020, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Matthew B. Hemington of Cooley LLP, counsel to the registrant, at (650) 843-5062.
[Signature page follows]
Sincerely,
INTERSECT ENT, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request INTERSECT ENT, INC. 1555 Adams Drive Menlo Park, CA 94025 June 15, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ada D. Sarmento RE: Intersect ENT, Inc. Registration Statement on Form S-3 File No. 333-238963 Acceleration Request Requested Date: June 17, 2020 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-238963) (the “Registration Statement”) to become effective at 4:00 p.m. Eastern Time on Wednesday, June 17, 2020, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Matthew B. Hemington of Cooley LLP, counsel to the registrant, at (650) 843-5062. [Signature page follows] Sincerely, INTERSECT ENT, INC. By: /s/ Thomas A. West Thomas A. West President and Chief Executive Officer cc: Richard A. Meier, Executive Vice President and Chief Financial Officer, Intersect ENT, Inc. Matthew B. Hemington, Cooley LLP